The Healing of Tobit by Bernardo Strozzi (CC0 1.0). There is ongoing discourse about the relationship between patient agency and external factors in health outcomes. It can be difficult to identify the multifaceted variables that answer the question of why one person becomes ill and not another. While individual action does certainly play a role,…Read More| Canopy Forum
Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like Ozempic. Not everyone is on board.| LevittownNow.com
Drugs solely approved to treat obesity have minimal to no coverage on most ACA Marketplace plans. Wegovy, a semaglutide approved for weight loss, is included in just 1% of Marketplace plans, while Ozempic, which has the same active ingredient but is approved for diabetes treatment and sometimes used off-label for weight loss, is included in 82% of Marketplace plan formularies. Among ACA Marketplace plans with these drugs on formulary, prior authorization is required by most plans. All plans ...| Peterson-KFF Health System Tracker